These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11368751)

  • 21. Cancer biomarker profiling with microRNAs.
    Jeffrey SS
    Nat Biotechnol; 2008 Apr; 26(4):400-1. PubMed ID: 18392022
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gene expression profiling in cancer research].
    Michiels S; Koscielny S; Boulet T; Hill C
    Bull Cancer; 2007 Nov; 94(11):976-80. PubMed ID: 18055315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.
    Rhodes DR; Chinnaiyan AM
    Ann N Y Acad Sci; 2004 May; 1020():32-40. PubMed ID: 15208181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology].
    Frolov AE; Godwin AK; Favorova OO
    Mol Biol (Mosk); 2003; 37(4):573-84. PubMed ID: 12942629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
    Sørensen KD; Ørntoft TF
    Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor vascular biomarkers: new opportunities for cancer diagnostics.
    Li C; Sasaroli D; Chen X; Hu J; Sandaltzopoulos R; Omidi Y; Coukos G
    Cancer Biomark; 2010-2011; 8(4-5):253-71. PubMed ID: 22045357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
    Auman JT
    Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiclass cancer classification and biomarker discovery using GA-based algorithms.
    Liu JJ; Cutler G; Li W; Pan Z; Peng S; Hoey T; Chen L; Ling XB
    Bioinformatics; 2005 Jun; 21(11):2691-7. PubMed ID: 15814557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1071-87. PubMed ID: 18070704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ
    J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ensemble machine learning on gene expression data for cancer classification.
    Tan AC; Gilbert D
    Appl Bioinformatics; 2003; 2(3 Suppl):S75-83. PubMed ID: 15130820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAGE and related approaches for cancer target identification.
    Porter D; Yao J; Polyak K
    Drug Discov Today; 2006 Feb; 11(3-4):110-8. PubMed ID: 16533708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cDNA microarrays: identification of gene signatures and their application in clinical practice.
    Magic Z; Radulovic S; Brankovic-Magic M
    J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes.
    Prieto C; Rivas MJ; Sánchez JM; López-Fidalgo J; De Las Rivas J
    Bioinformatics; 2006 May; 22(9):1103-10. PubMed ID: 16500942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 36. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
    Cosler LE; Lyman GH
    Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
    [No Abstract]   [Full Text] [Related]  

  • 37. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues.
    Scott A; Ambannavar R; Jeong J; Liu ML; Cronin MT
    Methods Mol Biol; 2011; 724():239-57. PubMed ID: 21370017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
    Auman JT; McLeod HL
    Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.